Sulforaphane-induced apoptosis involves p53 and p38 in melanoma cells

K Rudolf1, M Cervinka, E Rudolf

  • 1Department of Medical Biology and Genetics, Faculty of Medicine in Hradec Králové, Charles University in Prague, Šimkova 870, 500 38, Hradec Králové, Czech Republic.

Insights

Sulforaphane (SF) shows anti-cancer effects in melanoma by inducing cell death. While effective in cell lines, its efficiency is lower in fresh melanoma, suggesting potential combination therapies for better outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant melanoma exhibits complex reprogramming of cell death and survival pathways, leading to chemoresistance and poor prognosis.
  • Sulforaphane (SF), a compound from cruciferous plants, has demonstrated antiproliferative and proapoptotic activity in various cancer cell lines, including melanoma.

Purpose of the Study:

  • To investigate the cytotoxic and apoptotic effects of Sulforaphane (SF) on melanoma cell lines and fresh melanoma cultivates.
  • To elucidate the signaling pathways modulated by SF in melanoma, including oxidative stress, DNA damage response, and apoptosis-related proteins.

Main Methods:

  • Treatment of melanoma cell lines and fresh melanoma cultivates with Sulforaphane (SF).
  • Assessment of cytotoxicity and apoptosis induction (mitochondrial, caspase-dependent).
  • Analysis of signaling pathways, including oxidative stress markers, DNA-damage response, p38 kinase activity, Akt activity, and expression of proapoptotic proteins (Bax, Puma).

Main Results:

  • SF demonstrated cytotoxicity and induced mitochondrial, caspase-dependent apoptosis in melanoma cell lines, with lower efficiency in fresh cultivates.
  • SF triggered oxidative stress, DNA-damage response, altered p38 kinase activity, and increased Bax and Puma expression in melanoma cells.
  • In p53-mutant cells, Puma expression was p38-dependent; in fresh cultivates, Akt-mediated suppression of p38 and p53 potentially reduced SF-induced apoptosis.

Conclusions:

  • SF inhibits growth and induces mitochondrial apoptosis in both melanoma cell lines and fresh cultivates.
  • The proapoptotic effects of SF may be enhanced by combining it with Akt inhibitors, particularly in patient-derived melanoma samples.
  • SF warrants further preclinical investigation as a single agent or in combination therapies for melanoma treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K